<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="10521">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02969993</url>
  </required_header>
  <id_info>
    <org_study_id>2016/394</org_study_id>
    <nct_id>NCT02969993</nct_id>
  </id_info>
  <brief_title>Very Long Term VHI Voice Outcome After MTIS</brief_title>
  <official_title>Very Long Term VHI Voice Outcome After MTIS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Long term assesment of voice outcome after Montgomery Thyroplastie by performing a Survey of
      operated patients using the voice handicap index scale
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Voice handicap index</measure>
    <time_frame>2 years</time_frame>
    <description>Questionnaire</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Laryngeal Paralysis</condition>
  <arm_group>
    <arm_group_label>Questionnaire</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Questionnaire to previously operated patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaires</intervention_name>
    <description>evaluating the voice outcome by the fullfilment of the voice handicap index</description>
    <arm_group_label>Questionnaire</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients presenting UVFP of neurogenic origin treated by MTIS &gt; 2 years before
             inclusion.

          -  No superior limit in terms of years.

          -  Age 18-80 years at the time of MTIS

          -  No other treatment before MTIS other than resorbing material injection laryngoplasty
             (maximum twice)

          -  No further voice treatment after MTIS except speech therapy.

          -  VHI or VHI-10 performed before MTIS and within the 6 months after MTIS. In case of
             multiple post-op VHI tests, only the earliest post-op. VHI test will be taken into
             account

          -  VHI tests validated for the utilized language

        Exclusion Criteria:

          -  patient not able to answer VHI questionnaire personally

          -  Post MTIS new health condition affecting the voice tract and/ or the respiratory
             function.

          -  Post MTIS appearance of other voice/ vocal cord pathology
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gauthier Desuter, MD</last_name>
    <phone>003227641355</phone>
    <email>gauthier.desuter@uclouvain.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cliniques universitaires Saint-Luc</name>
      <address>
        <city>Brussels Capital Region</city>
        <state>Brussels</state>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gauthier R desuter, MD</last_name>
      <phone>027641355</phone>
      <email>gauthier.desuter@uclouvain.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Namur -Mont-Godinne</name>
      <address>
        <city>Yvoir</city>
        <state>Namur</state>
        <zip>5530</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastien Van Der Vorst, MD PhD</last_name>
      <phone>003281423705</phone>
      <email>sebastien.vandervorst@uclouvain.be</email>
    </contact>
    <investigator>
      <last_name>Sebastien Van Der Vorst, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Medico Nacional &quot; 20 de Noviembre &quot; &quot; ISSSTE</name>
      <address>
        <city>Mexico Distrito Federal</city>
        <zip>03100</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mastuharu Akaki Caballero, MD PhD</last_name>
      <phone>5215539003323</phone>
      <email>drmastuakaki@gamail.com</email>
    </contact>
    <investigator>
      <last_name>Mastuharu Akaki Caballero, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Valencia Medical School - Hospital General Universitario</name>
      <address>
        <city>Valencia</city>
        <state>Levante</state>
        <zip>46014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enrique Zapater Latorre, MD PhD</last_name>
      <phone>0034651991108</phone>
      <email>ezapaterlatorre@yahoo.es</email>
    </contact>
    <investigator>
      <last_name>Enrique Zapater Latorre, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Mexico</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 20, 2017</lastchanged_date>
  <firstreceived_date>November 18, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Paralysis</mesh_term>
    <mesh_term>Vocal Cord Paralysis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
